In Brief: OTC "feedback" meeting on hydroquinone

Executive Summary

OTC "feedback" meeting on hydroquinone: FDA will meet with representatives from Kodak, Dep, Medicis Pharmaceutical, Kiwi Brands, the American Health Foundation and the Nonprescription Drug Manufacturers Association to discuss the skin bleaching ingredient on Dec. 4 at 1 p.m. in Conference Room S-300, 9201 Corporate Blvd., Rockville, Md. The meeting, which is open to the public, is part of an otherwise-closed all-day session of the Carcinogenicity Assessment Committee. FDA held a "feedback" meeting to collect information on the ingredient's possible link to skin discoloration in July ("The Tan Sheet" July 15, p. 9)...